Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Chimerix Inc (NASDAQ:CMRX)

5.14
Delayed Data
As of 3:59pm ET
 -0.40 / -7.22%
Today’s Change
3.50
Today|||52-Week Range
9.34
+11.74%
Year-to-Date

Today’s Trading

Previous close5.54
Today’s open5.51
Day’s range5.05 - 5.54
Volume1,102,358
Average volume (3 months)546,504
Market cap$256.6M
Dividend yield--
Data as of 3:59pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)-48.33%
Earnings growth (this year)+35.43%
Earnings growth (next 5 years)--
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales36.49
Price/Book0.76

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc+0.40+9.41%
ZGNXZogenix Inc-0.30-3.53%
ZYNEZynerba Pharmaceutic...+0.03+0.17%
CNCEConcert Pharmaceutic...+0.14+1.51%
Data as of 4:00pm ET, 01/24/2017

Financials

Next reporting dateMarch 10, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$10.8M
Annual profit (last year)-$117.4M
Net profit margin-1,090.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
M. Michelle Berrey
Chief Financial Officer, Secretary &
Senior VP
Timothy W. Trost
Corporate headquarters
Durham, North Carolina

Forecasts


Search for Jobs